Glaxo plc Agrees to Divest Assets and Obtain Commission Approval for Migraine Drug Acquisitions

Summary

Glaxo plc has agreed to settle allegations of prohibited trade practices by divesting Wellcome's non-injectable drug research and development assets within nine months, and obtaining Commission approval for future acquisitions of migraine drug entities for ten years.

Original source language: Federal Register — Federal Trade CommissionOpen original release →

Add your company to Business Communicator

We monitor business sources and connect attention with companies, profiles and services available in Business Communicator.

Create a free company profile Explore businesses on Business Maps →

Create a free company profile →

Explore insights

Business insights →

Global Markets News Trade Regulation News Business Technology News Fintech for Business: Payments & Banking News Supply Chain News Central Bank Policy News

LATEST SIGNALS

Market regulation · 9/10/2026

FTC Seeks Public Comment on Proposed 2027 Budget for Horseracing Integrity and Safety Authority

The Federal Trade Commission has released its proposed 2027 budget for the Horseracing Integrity and Safety Authority, inviting public comment on whether to approve, disapprove, or modify the budget.

Read summary →

Market regulation · 8/26/2026

Federal Trade Commission Amends Telemarketing Sales Rule Fees

The Federal Trade Commission is updating the fees charged to companies accessing the National Do Not Call Registry, as mandated by the 2007 Do-Not-Call Registry Fee Extension Act.

Read summary →

Market regulation · 8/25/2026

Federal Trade Commission Seeks Public Comment on Extension of Safeguards Rule Information Collection Requirements

The Federal Trade Commission is requesting public comment on its proposal to extend the information collection requirements of the Safeguards Rule for an additional three years, with the current clearance set to expire on December 31, 2026.

Read summary →

Market regulation · 8/18/2026

FTC Requests Extension of Franchise Rule Clearance Under Paperwork Reduction Act

The Federal Trade Commission (FTC) is requesting the Office of Management and Budget (OMB) to extend the clearance for its Franchise Rule for three more years, until August 31, 2029, due to its expiration on August 31, 2026.

Read summary →

Market regulation · 8/14/2026

Federal Trade Commission Seeks Public Comment on Paperwork Reduction Act Clearance Extension

The Federal Trade Commission is requesting public comment on an extension of its current Paperwork Reduction Act clearance for three more years, which would allow it to continue participating in the Office of Management and Budget's Generic Clearance for the Collection of Qualitative Feedback on Service Delivery until August 30, 2029.

Read summary →

Market regulation · 8/14/2026

Federal Trade Commission Publishes Regulatory Agenda

The Federal Trade Commission has published its regulatory agenda, outlining the regulatory actions under development or review, in accordance with the Federal Trade Commission Act and the Regulatory Flexibility Act, and will be available on the Government-wide Unified Agenda website.

Read summary →